Li CS - Search Results

1

Fibroblast growth factor receptor 4 as a potential prognostic and therapeutic marker in colorectal cancer.

Li CS, Zhang SX, Liu HJ, Shi YL, Li LP, Guo XB, Zhang ZH. Li CS, et al. Among authors: li lp. Biomarkers. 2014 Feb;19(1):81-5. doi: 10.3109/1354750X.2013.876555. Epub 2014 Jan 13. Biomarkers. 2014. PMID: 24410190

2

Down-regulation of VEZT gene expression in human gastric cancer involves promoter methylation and miR-43c.

Guo X, Jing C, Li L, Zhang L, Shi Y, Wang J, Liu J, Li C. Guo X, et al. Biochem Biophys Res Commun. 2011 Jan 14;404(2):622-7. doi: 10.1016/j.bbrc.2010.12.026. Epub 2010 Dec 13. Biochem Biophys Res Commun. 2011. PMID: 21156161

3

Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene.

Guo XB, Jing CQ, Li LP, Zhang L, Shi YL, Wang JS, Liu JL, Li CS. Guo XB, et al. Among authors: li cs, li lp. World J Gastroenterol. 2011 Apr 14;17(14):1895-902. doi: 10.3748/wjg.v17.i14.1895. World J Gastroenterol. 2011. PMID: 21528065 Free PMC article.

4

Lack of association of MiR-34b/c polymorphism (rs4938723) with hepatocellular carcinoma: a meta-analysis.

Liang TJ, Liu HJ, Zhao XQ, Yu CH, Li CS. Liang TJ, et al. Among authors: li cs. PLoS One. 2013 Jul 31;8(7):e68588. doi: 10.1371/journal.pone.0068588. Print 2013. PLoS One. 2013. PMID: 23935875 Free PMC article.

5

VEZT, a novel putative tumor suppressor, suppresses the growth and tumorigenicity of gastric cancer.

Miao R, Guo X, Zhi Q, Shi Y, Li L, Mao X, Zhang L, Li C. Miao R, et al. PLoS One. 2013 Sep 17;8(9):e74409. doi: 10.1371/journal.pone.0074409. eCollection 2013. PLoS One. 2013. PMID: 24069310 Free PMC article.

6

STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells.

Akhtar J, Wang Z, Yu C, Li CS, Shi YL, Liu HJ. Akhtar J, et al. Among authors: li cs. BMC Cancer. 2014 Jan 16;14:28. doi: 10.1186/1471-2407-14-28. BMC Cancer. 2014. Retraction in: BMC Cancer. 2015 Mar 26;15:187. doi: 10.1186/s12885-015-1162-8 PMID: 24433541 Free PMC article. Retracted.

7

Retraction note: STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells.

Akhtar J, Wang Z, Yu C, Li CS, Shi YL, Liu HJ. Akhtar J, et al. Among authors: li cs. BMC Cancer. 2015 Mar 26;15:187. doi: 10.1186/s12885-015-1162-8. BMC Cancer. 2015. PMID: 25886147 Free PMC article. No abstract available.

8

Livin serves as a prognostic marker for mid-distal rectal cancer and a target of mid-distal rectal cancer treatment.

Su QB, Wang LY, Wei GN, Liao LZ, Zhao J, Liu HJ, Shi YL, Li LP, Li CS. Su QB, et al. Among authors: li cs, li lp. Oncol Lett. 2017 Dec;14(6):7759-7766. doi: 10.3892/ol.2017.7230. Epub 2017 Oct 20. Oncol Lett. 2017. PMID: 29344221 Free PMC article.

9

Silencing Livin improved the sensitivity of colon cancer cells to 5-fluorouracil by regulating crosstalk between apoptosis and autophagy.

Liu S, Li X, Li Q, Liu H, Shi Y, Zhuo H, Li C, Zhu H. Liu S, et al. Oncol Lett. 2018 May;15(5):7707-7715. doi: 10.3892/ol.2018.8282. Epub 2018 Mar 16. Oncol Lett. 2018. PMID: 29740490 Free PMC article.

10

Usefulness of large-section cytokeratin 20 in the detection of intestinal wall infiltration and mesangial metastasis in patients with middle and lower rectal cancer.

Shan KS, Zhang XP, Wang JS, Guo XB, Shang L, Tian F, Jing CQ, Li LP, Wan DS, Li CS. Shan KS, et al. Among authors: li cs, li lp. J Cancer Res Ther. 2019;15(2):437-441. doi: 10.4103/jcrt.JCRT_405_18. J Cancer Res Ther. 2019. PMID: 30964123 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,353 results

Search Page

Filters